Reversal of multidrug resistance in drug-resistant human gastric cancer cell line SGC7901/VCR by antiprogestin drug mifepristone

doi:10.3748/wjg.v10.i12.1722

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2933)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

342

HTML

2128

Figures (1-2)

222

Tables (1-4)

241

Sum=2933

Jun 15, 2004 (publication date) through Dec 21, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. Jun 15, 2004; 10(12): 1722-1725
Published online Jun 15, 2004. doi: 10.3748/wjg.v10.i12.1722

Full Size Figure Download Figure

Figure 2 Western blotting analysis of Bcl-2 and Bax proteins in cellular extracts of SGC7901/ VCR cells cultured for 96 h in the absence or the presence of miferpstone. Lane1-3: control, 1 μmol/L and 10 μmol/L mifepristone, respectively.

Citation: Li DQ, Wang ZB, Bai J, Zhao J, Wang Y, Hu K, Du YH. Reversal of multidrug resistance in drug-resistant human gastric cancer cell line SGC7901/VCR by antiprogestin drug mifepristone. World J Gastroenterol 2004; 10(12): 1722-1725
URL: https://www.wjgnet.com/1007-9327/full/v10/i12/1722.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i12.1722